Unilever Profit Jumps 127% in 2025 After Ice Cream Divestment

JAKARTA, Investortrust.id — PT Unilever Indonesia Tbk or UNVR reports a 127% surge in net profit on Thursday, Feb 12, 2026 in Jakarta to Rp 7.64 trillion, equal to $490 million, in 2025 driven largely by gains from discontinued operations following the divestment of its ice cream business, strengthening cash reserves and boosting shareholder returns.

PT Unilever Indonesia Tbk said net profit jumped 127% to Rp 7.64 trillion from Rp 3.36 trillion in the previous year as the company recorded a Rp 3.79 trillion gain from the divestment of a subsidiary.

Net sales rose 4.31% to Rp 31.94 trillion from Rp 30.62 trillion, while gross profit increased 3.02% to Rp 14.99 trillion from Rp 14.55 trillion.

Operating profit climbed 20.79% to Rp 4.59 trillion from Rp 3.80 trillion as marketing as well as general and administrative expenses declined.

EBITDA grew 18.74% to Rp 5.26 trillion from Rp 4.43 trillion, while earnings per share advanced 22.37% to Rp 93 from Rp 76.

The company completed the sale of PT The Magnum Ice Cream Indonesia on Monday, Dec 8, 2025 for Rp 7 trillion excluding value added tax.

Management said the proceeds would be distributed as cash dividends once the transaction was finalized, providing immediate returns to shareholders.

The divestment was also aimed at strengthening the company’s cash position, reducing reliance on external funding, and sharpening its focus on core segments of home and personal care as well as nutrition.

Valuation and Market View

Despite the earnings surge, UNVR shares have declined sharply over the past five years amid growth concerns and valuation compression.

Based on InvestingPro data, UNVR closed at Rp 2,260 with a 52 week trading range of Rp 985 to Rp 2,840. The platform estimates a fair value of Rp 2,788.26 per share, implying a potential upside of 23.4% from the latest closing price, with medium uncertainty.

Analyst targets from 18 analysts range between Rp 1,300 and Rp 3,400, reflecting divergent views on the company’s recovery trajectory. Financial health indicators show strong profitability and stable cash flow, although growth metrics remain weak, suggesting the recent profit jump was driven more by one off divestment gains than structural expansion.